131 related articles for article (PubMed ID: 29540533)
1. Serum, liver and bile sitosterol and sitostanol in obese patients with and without NAFLD.
Tauriainen MM; Männistö V; Kaminska D; Vaittinen M; Kärjä V; Käkelä P; Venesmaa S; Gylling H; Pihlajamäki J
Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29540533
[No Abstract] [Full Text] [Related]
2. Serum Plant Sterols Associate with Gallstone Disease Independent of Weight Loss and Non-Alcoholic Fatty Liver Disease.
Käkelä P; Männistö V; Ilves I; Vaittinen M; Tauriainen MM; Eskelinen M; Gylling H; Paajanen H; Pihlajamäki J
Obes Surg; 2017 May; 27(5):1284-1291. PubMed ID: 27812789
[TBL] [Abstract][Full Text] [Related]
3. Hepatic transport and secretion of unesterified cholesterol in the rat is traced by the plant sterol, sitostanol.
Robins SJ; Fasulo JM; Pritzker CR; Patton GM
J Lipid Res; 1996 Jan; 37(1):15-21. PubMed ID: 8820098
[TBL] [Abstract][Full Text] [Related]
4. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
[TBL] [Abstract][Full Text] [Related]
5. Comment on Tauriainen et al.: Serum, liver and bile sitosterol and sitostanol in obese patients with and without NAFLD.
Plat J; Baumgartner S; Houben T; Vreugdenhil ACE; Mensink RP; Lütjohann D; Shiri-Sverdlov R
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30287500
[TBL] [Abstract][Full Text] [Related]
6. Non-cholesterol sterols in serum and endarterectomized carotid arteries after a short-term plant stanol and sterol ester challenge.
Miettinen TA; Nissinen M; Lepäntalo M; Albäck A; Railo M; Vikatmaa P; Kaste M; Mustanoja S; Gylling H
Nutr Metab Cardiovasc Dis; 2011 Mar; 21(3):182-8. PubMed ID: 20096545
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the hepatic clearances of campesterol, sitosterol, and cholesterol in healthy subjects suggests that efflux transporters controlling intestinal sterol absorption also regulate biliary secretion.
Sudhop T; Sahin Y; Lindenthal B; Hahn C; Lüers C; Berthold HK; von Bergmann K
Gut; 2002 Dec; 51(6):860-3. PubMed ID: 12427790
[TBL] [Abstract][Full Text] [Related]
8. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
Friedrich D; Marschall HU; Lammert F
BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
[TBL] [Abstract][Full Text] [Related]
9. Dietary plant stanols or sterols neither accumulate in stenotic aortic valves nor influence their structure or inflammatory status.
Simonen P; Lommi J; Hallikainen M; Helske-Suihko S; Werkkala K; Kupari M; Kovanen PT; Gylling H
Clin Nutr; 2015 Dec; 34(6):1251-7. PubMed ID: 25614126
[TBL] [Abstract][Full Text] [Related]
10. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
11. The presence of 5 alpha-sitostanol in the serum of a patient with phytosterolemia, and its biosynthesis from plant steroids in rats with bile fistula.
Skrede B; Björkhem I; Bergesen O; Kayden HJ; Skrede S
Biochim Biophys Acta; 1985 Oct; 836(3):368-75. PubMed ID: 4041477
[TBL] [Abstract][Full Text] [Related]
12. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
Asai Y; Yamada T; Tsukita S; Takahashi K; Maekawa M; Honma M; Ikeda M; Murakami K; Munakata Y; Shirai Y; Kodama S; Sugisawa T; Chiba Y; Kondo Y; Kaneko K; Uno K; Sawada S; Imai J; Nakamura Y; Yamaguchi H; Tanaka K; Sasano H; Mano N; Ueno Y; Shimosegawa T; Katagiri H
Gastroenterology; 2017 May; 152(6):1521-1535.e8. PubMed ID: 28088462
[TBL] [Abstract][Full Text] [Related]
13. Soy sterol esters and beta-sitostanol ester as inhibitors of cholesterol absorption in human small bowel.
Normén L; Dutta P; Lia A; Andersson H
Am J Clin Nutr; 2000 Apr; 71(4):908-13. PubMed ID: 10731496
[TBL] [Abstract][Full Text] [Related]
14. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
15. Competitive inhibition of hepatic sterol 27-hydroxylase by sitosterol: decreased activity in sitosterolemia.
Nguyen LB; Shefer S; Salen G; Tint SG; Batta AK
Proc Assoc Am Physicians; 1998; 110(1):32-9. PubMed ID: 9460081
[TBL] [Abstract][Full Text] [Related]
16. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
Torun E; Aydın S; Gökçe S; Özgen İT; Donmez T; Cesur Y
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():92-8. PubMed ID: 25910377
[TBL] [Abstract][Full Text] [Related]
17. Serum leptin and leptin resistance correlations with NAFLD in patients with type 2 diabetes.
Cernea S; Roiban AL; Both E; Huţanu A
Diabetes Metab Res Rev; 2018 Nov; 34(8):e3050. PubMed ID: 30052309
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
[TBL] [Abstract][Full Text] [Related]
19. Reduced circulating levels of sTWEAK are associated with NAFLD and may affect hepatocyte triglyceride accumulation.
Lozano-Bartolomé J; Llauradó G; Rodriguez MM; Fernandez-Real JM; Garcia-Fontgivell JF; Puig J; Maymó-Masip E; Vendrell J; Chacón MR
Int J Obes (Lond); 2016 Sep; 40(9):1337-45. PubMed ID: 27121253
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity.
Simonen P; Kotronen A; Hallikainen M; Sevastianova K; Makkonen J; Hakkarainen A; Lundbom N; Miettinen TA; Gylling H; Yki-Järvinen H
J Hepatol; 2011 Jan; 54(1):153-9. PubMed ID: 20947198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
